Trials / Completed
CompletedNCT01098071
Nasonex (Mometasone Furoate Nasal Spray) in Adenoids Hypertrophy in Children (P04367)
Open Label Pilot Trial, Evaluating the Role of Nasonex in the Management of Nasal Obstruction Secondary to Adenoids Hypertrophy in Children
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 34 (actual)
- Sponsor
- Organon and Co · Industry
- Sex
- All
- Age
- 2 Years – 11 Years
- Healthy volunteers
- Not accepted
Summary
To document the short term \& long term effect of treatment with Nasonex (mometasone furoate nasal spray) in moderate to severe adenoids hypertrophy (which cause \> 50% obstruction of the posterior choanae).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | mometasone furoate nasal spray | One spray (50 mcg per spray) in each nostril once daily (100 mcg daily) for 3 months |
Timeline
- Start date
- 2008-08-01
- Primary completion
- 2009-09-01
- Completion
- 2009-09-01
- First posted
- 2010-04-02
- Last updated
- 2024-05-28
- Results posted
- 2011-11-29
Source: ClinicalTrials.gov record NCT01098071. Inclusion in this directory is not an endorsement.